We further explored the predictive potential of HAVOC for heterogeneously proliferating subclones in another independent cohort of glioblastomas assembled to contain cases that displayed regional variations in Ki-67 (n = 5, table S2). The gene discussed is MKI67; the disease is glioblastoma.